Portola Pharma (PTLA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
(Values in U.S. thousands)
| 12-2019 | 12-2018 | 12-2017 | 12-2016 | 12-2015 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 218,650 | 140,013 | 181,741 | 188,658 | 186,829 |
| Marketable Securities | 214,054 | 178,013 | 281,589 | 130,291 | 257,713 |
| Receivables | 13,547 | 5,849 | 3,750 | N/A | 1,000 |
| Inventories | 4,101 | 7,873 | 1,099 | N/A | N/A |
| Other current assets | 3,783 | 9,880 | 0 | 7,299 | 16,976 |
| TOTAL | $462,133 | $353,327 | $477,923 | $328,928 | $465,577 |
| Non-Current Assets | |||||
| PPE Net | 4,264 | 5,236 | 5,217 | 6,143 | 6,243 |
| Investments And Advances | 36,961 | 0 | 71,076 | 0 | 15,960 |
| Intangibles | 0 | 7,279 | 7,851 | 3,151 | 3,151 |
| Other Non-Current Assets | 75,125 | 20,577 | 9,609 | 5,214 | 11,993 |
| TOTAL | $116,350 | $33,092 | $93,753 | $14,508 | $37,347 |
| Total Assets | $578,483 | $386,419 | $571,676 | $343,436 | $502,924 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 12,739 | 13,215 | 9,304 | 14,546 | 10,279 |
| Accrued Expenses | 69,022 | 42,141 | 48,525 | 25,514 | 27,021 |
| TOTAL | $102,418 | $69,005 | $80,524 | $65,664 | $51,146 |
| Non-Current Liabilities | |||||
| Long Term Debt | 332,943 | 203,554 | 104,816 | 49,815 | N/A |
| Deferred Revenues | 1,623 | 1,847 | 11,169 | 20,798 | 8,387 |
| Other Non-Current Liabilities | 11,158 | 19,126 | 17,575 | 9,373 | 2,826 |
| TOTAL | $346,240 | $226,847 | $141,659 | $85,083 | $21,455 |
| Total Liabilities | $448,658 | $295,852 | $222,183 | $150,747 | $72,601 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 78,080 | 66,821 | 65,392 | 56,557 | 56,362 |
| Common Shares | 80 | 68 | 66 | 57 | 57 |
| Retained earnings | -1,816,367 | -1,525,704 | -1,204,519 | -918,345 | -649,302 |
| Other shareholders' equity | 35 | 1,883 | 2,218 | 2,145 | 2,777 |
| TOTAL | $129,825 | $90,567 | $349,493 | $192,689 | $430,323 |
| Total Liabilities And Equity | $578,483 | $386,419 | $571,676 | $343,436 | $502,924 |